These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7618087)

  • 1. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.
    Doody GM; Justement LB; Delibrias CC; Matthews RJ; Lin J; Thomas ML; Fearon DT
    Science; 1995 Jul; 269(5221):242-4. PubMed ID: 7618087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
    Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
    J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
    Greer SF; Justement LB
    J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C.
    Campbell MA; Klinman NR
    Eur J Immunol; 1995 Jun; 25(6):1573-9. PubMed ID: 7542197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22.
    Blasioli J; Paust S; Thomas ML
    J Biol Chem; 1999 Jan; 274(4):2303-7. PubMed ID: 9890995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD22 is a functional ligand for SH2 domain-containing protein-tyrosine phosphatase-1 in primary T cells.
    Sathish JG; Walters J; Luo JC; Johnson KG; Leroy FG; Brennan P; Kim KP; Gygi SP; Neel BG; Matthews RJ
    J Biol Chem; 2004 Nov; 279(46):47783-91. PubMed ID: 15364920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation.
    Tuscano J; Engel P; Tedder TF; Kehrl JH
    Blood; 1996 Jun; 87(11):4723-30. PubMed ID: 8639842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the B cell by CD22: a requirement for Lyn.
    Smith KG; Tarlinton DM; Doody GM; Hibbs ML; Fearon DT
    J Exp Med; 1998 Mar; 187(5):807-11. PubMed ID: 9480991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
    Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
    Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
    Cornall RJ; Goodnow CC; Cyster JG
    Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligation.
    Lankester AC; van Schijndel GM; van Lier RA
    J Biol Chem; 1995 Sep; 270(35):20305-8. PubMed ID: 7657601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1.
    Wu Y; Nadler MJ; Brennan LA; Gish GD; Timms JF; Fusaki N; Jongstra-Bilen J; Tada N; Pawson T; Wither J; Neel BG; Hozumi N
    Curr Biol; 1998 Sep; 8(18):1009-17. PubMed ID: 9740800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1.
    Otipoby KL; Draves KE; Clark EA
    J Biol Chem; 2001 Nov; 276(47):44315-22. PubMed ID: 11551923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop.
    Fujimoto M; Bradney AP; Poe JC; Steeber DA; Tedder TF
    Immunity; 1999 Aug; 11(2):191-200. PubMed ID: 10485654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of B cell receptor-associated signaling molecules in human lupus.
    Huck S; Le Corre R; Youinou P; Zouali M
    Autoimmunity; 2001 May; 33(3):213-24. PubMed ID: 11683380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
    Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
    J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
    Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
    Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of CD22 during B cell activation.
    Schulte RJ; Campbell MA; Fischer WH; Sefton BM
    Science; 1992 Nov; 258(5084):1001-4. PubMed ID: 1279802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyn/CD22/SHP-1 and their importance in autoimmunity.
    Blasioli J; Goodnow CC
    Curr Dir Autoimmun; 2002; 5():151-60. PubMed ID: 11826756
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.